178 related articles for article (PubMed ID: 23315031)
1. Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.
Evang JA; Bollerslev J; Casar-Borota O; Lekva T; Ramm-Pettersen J; Berg JP
Endocrine; 2013 Aug; 44(1):220-7. PubMed ID: 23315031
[TBL] [Abstract][Full Text] [Related]
2. Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours.
Evang JA; Berg JP; Casar-Borota O; Lekva T; Kringen MK; Ramm-Pettersen J; Bollerslev J
Clin Endocrinol (Oxf); 2011 Dec; 75(6):811-8. PubMed ID: 21595730
[TBL] [Abstract][Full Text] [Related]
3. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
4. Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.
Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
Endocrine; 2017 Mar; 55(3):853-860. PubMed ID: 27220856
[TBL] [Abstract][Full Text] [Related]
5. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
7. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T
Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928
[TBL] [Abstract][Full Text] [Related]
8. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
[TBL] [Abstract][Full Text] [Related]
9. Role of NeuroD1 on the negative regulation of Pomc expression by glucocorticoid.
Parvin R; Saito-Hakoda A; Shimada H; Shimizu K; Noro E; Iwasaki Y; Fujiwara K; Yokoyama A; Sugawara A
PLoS One; 2017; 12(4):e0175435. PubMed ID: 28406939
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression and gene expression profiles in corticotroph pituitary neuroendocrine tumor subtypes.
Kiseljak-Vassiliades K; Lipe K; Turin CG; Fishbein L; Costello JC; Kerr JM; Holmstoen TB; Youssef AS; Lillehei KO; Kleinschmidt-DeMasters BK; Wierman ME
J Neuropathol Exp Neurol; 2024 Jun; 83(7):586-595. PubMed ID: 38777808
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
15. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.
Tateno T; Izumiyama H; Doi M; Akashi T; Ohno K; Hirata Y
Endocr J; 2007 Dec; 54(5):777-82. PubMed ID: 17917309
[TBL] [Abstract][Full Text] [Related]
16. Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas.
Pecori Giraldi F; Cassarino MF; Sesta A; Lasio G; Losa M
Neuroendocrinology; 2023; 113(6):606-614. PubMed ID: 36791678
[TBL] [Abstract][Full Text] [Related]
17. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs.
Vallette-Kasic S; Figarella-Branger D; Grino M; Pulichino AM; Dufour H; Grisoli F; Enjalbert A; Drouin J; Brue T
J Clin Endocrinol Metab; 2003 Jul; 88(7):3050-6. PubMed ID: 12843142
[TBL] [Abstract][Full Text] [Related]
19. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing.
Sesta A; Cassarino MF; Terreni M; Ambrogio AG; Libera L; Bardelli D; Lasio G; Losa M; Pecori Giraldi F
Neuroendocrinology; 2020; 110(1-2):119-129. PubMed ID: 31280266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
